Position in ABBV
as of Mar 31, 2026
· filed Apr 23, 2026
Position Value
$546,117
-$19,624 QoQ
Shares Held
2,511
+1.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.74%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 90%
Shared 0%
None 10%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Catalina Capital Group, LLC holds $2,098,375 across 4 Drug Manufacturers - General names. ABBV ranks #2 (26.0% of the industry book) .
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $546,117 | 2,511 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $565,741 | 2,476 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $577,692 | 2,495 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $460,708 | 2,482 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $680,730 | 3,249 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $1,896,059 | 10,670 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,997,115 | 10,113 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $1,579,699 | 9,210 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,259,767 | 6,918 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $509,851 | 3,290 | Shares | Sole | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||